21 U.S.C. § 1523 — Definitions

Page 941 TITLE 21—FOOD AND DRUGS § 1523 ‘‘(E) $5,900,000,000 in mental health and develop- mental disabilities (31 percent of mental health spending). ‘‘(F) $1,500,000,000 in public safety (26 percent of public safety spending) and $400,000,000 for the state workforce. ‘‘(8) Intergovernmental cooperation and coordina- tion through national, State, and local or tribal lead- ership and partnerships are critical to facilitate the reduction of substance abuse among youth in commu- nities across the United States. ‘‘(9) Substance abuse is perceived as a much greater problem nationally than at the community level. Ac- cording to a 2001 study sponsored by The Pew Chari- table Trusts, between 1994 and 2000— ‘‘(A) there was a 43 percent increase in the per- centage of Americans who felt progress was being made in the war on drugs at the community level; ‘‘(B) only 9 percent of Americans say drug abuse is a ‘crisis’ in their neighborhood, compared to 27 percent who say this about the nation; and ‘‘(C) the percentage of those who felt we lost ground in the war on drugs on a community level fell by more than a quarter, from 51 percent in 1994 to 37 percent in 2000.’’ AUTHORIZATION FOR NATIONAL COMMUNITY ANTIDRUG COALITION INSTITUTE Pub. L. 107–82, § 4, Dec. 14, 2001, 115 Stat. 821, as amended by Pub. L. 109–469, title VIII, § 805, Dec. 29, 2006, 120 Stat. 3535; Pub. L. 115–271, title VIII, § 8204, Oct. 24, 2018, 132 Stat. 4112; Pub. L. 116–74, § 2(e), Nov. 27, 2019, 133 Stat. 1159, provided that: ‘‘(a) IN GENERAL.—Beginning in fiscal year 2020, the Director shall make a competitive grant to provide for the continuation of the National Community Anti-drug [sic] Coalition Institute. ‘‘(b) ELIGIBLE ORGANIZATIONS.—An organization eligi- ble for the grant under subsection (a) is any national nonprofit organization that represents, provides tech- nical assistance and training to, and has special exper- tise and broad, national-level experience in community antidrug coalitions under this subchapter [sic, probably means chapter 2 of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1521 et seq.)]. ‘‘(c) USE OF GRANT AMOUNT.—The organization that receives the grant under subsection (a) shall continue a National Community Anti-Drug [sic] Coalition Insti- tute to— ‘‘(1) provide education, training, and technical as- sistance for coalition leaders and community teams, with emphasis on the development of coalitions serv- ing economically disadvantaged areas; ‘‘(2) develop and disseminate evaluation tools, mechanisms, and measures to better assess and docu- ment coalition performance measures and outcomes; and ‘‘(3) bridge the gap between research and practice by translating knowledge from research into prac- tical information. ‘‘(d) ADMINISTRATION OF GRANT.— ‘‘(1) DURATION.—With respect to a grant made under subsection (a) in fiscal year 2020, the term of the grant shall be 4 years. ‘‘(2) DISBURSEMENT.—To the extent amounts are provided in appropriation Acts for such grant, the Di- rector shall disburse the amount of the grant made under subsection (a) on an annual basis.’’ PROHIBITION AGAINST DUPLICATION OF EFFORT Pub. L. 107–82, § 5, Dec. 14, 2001, 115 Stat. 821, provided that: ‘‘The Director of the Office of National Drug Con- trol Policy shall ensure that the same or similar activi- ties are not carried out, through the use of funds for ad- ministrative costs provided under subchapter II [prob- ably means chapter 2] of the National Narcotics Lead- ership Act of 1988 (21 U.S.C. 1521 et seq.) or funds pro- vided under section 4 of this Act [set out as a note above], by more than one recipient of such funds.’’ § 1522. Purposes The purposes of this subchapter are— (1) to reduce substance use and misuse among youth in communities throughout the United States, and over time, to reduce sub- stance use and misuse among adults; (2) to strengthen collaboration among com- munities, the Federal Government, and State, local, and tribal governments; (3) to enhance intergovernmental coopera- tion and coordination on the issue of sub- stance use and misuse among youth; (4) to serve as a catalyst for increased cit- izen participation and greater collaboration among all sectors and organizations of a com- munity that first demonstrates a long-term commitment to reducing substance use and misuse among youth; (5) to rechannel resources from the fiscal year 1998 Federal drug control budget to pro- vide technical assistance, guidance, and finan- cial support to communities that demonstrate a long-term commitment in reducing sub- stance use and misuse among youth; (6) to disseminate to communities timely in- formation regarding the state-of-the-art prac- tices and initiatives that have proven to be ef- fective in reducing substance use and misuse among youth; (7) to enhance, not supplant, local commu- nity initiatives for reducing substance use and misuse among youth; and (8) to encourage the creation of and support for community anti-drug coalitions through- out the United States. (Pub. L. 100–690, title I, § 1022, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225; amended Pub. L. 115–271, title VIII, § 8203(b)(1), Oct. 24, 2018, 132 Stat. 4111; Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), Nov. 27, 2019, 133 Stat. 1157.) Editorial Notes AMENDMENTS 2019—Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(1). See 2018 Amendment note below. 2018—Pub. L. 115–271, § 8203(b)(1), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), substituted ‘‘substance use and misuse’’ for ‘‘substance abuse’’ wherever appearing. Statutory Notes and Related Subsidiaries EFFECTIVE DATE OF 2019 AMENDMENT Pub. L. 116–74, § 2(c)(2), Nov. 27, 2019, 133 Stat. 1158, provided that: ‘‘The amendments made by this sub- section [amending this section, sections 1506, 1523, 1524, 1531 to 1533, 1535, 1541 to 1548, and 1705 of this title, and provisions set out as notes under sections 1521, 1524, and 1532 of this title] shall take effect as if included in the enactment of the Substance Abuse Prevention Act of 2018 (subtitle K of title VIII of Public Law 115–271) [see Tables for classification].’’ § 1523. Definitions In this subchapter: (1) Administrator The term ‘‘Administrator’’ means the Ad- ministrator appointed by the Director under section 1531(c) of this title. Page 942 TITLE 21—FOOD AND DRUGS § 1524 1 See References in Text note below. 2 So in original. (2) Advisory Commission The term ‘‘Advisory Commission’’ means the Advisory Commission established under sec- tion 1541 1 of this title. (3) Community The term ‘‘community’’ shall have the meaning provided that term by the Adminis- trator, in consultation with the Advisory Commission. (4) Director The term ‘‘Director’’ means the Director of the Office of National Drug Control Policy. (5) Eligible coalition The term ‘‘eligible coalition’’ means a coali- tion that meets the applicable criteria under section 1532(a) of this title. (6) Grant recipient The term ‘‘grant recipient’’ means the re- cipient of a grant award under section 1532 of this title. (7) Nonprofit organization The term ‘‘nonprofit organization’’ means an organization described under section 501(c)(3) of title 26 that is exempt from taxation under section 501(a) of title 26. (8) Program The term ‘‘Program’’ means the program es- tablished under section 1531(a) of this title. (9) Substance use and misuse The term ‘‘substance use and misuse’’ means— (A) the illegal use or misuse of drugs, in- cluding substances for which a listing is ef- fect 2 under any of schedules I through V under section 812 of this title; (B) the misuse of inhalants or over-the- counter drugs; or (C) the use of alcohol, tobacco, or other re- lated product as such use is prohibited by State or local law. (10) Youth The term ‘‘youth’’ shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission. (Pub. L. 100–690, title I, § 1023, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225; amended Pub. L. 115–271, title VIII, § 8203(b)(2), Oct. 24, 2018, 132 Stat. 4111; Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), Nov. 27, 2019, 133 Stat. 1157.) Editorial Notes REFERENCES IN TEXT Section 1541 of this title, referred to in par. (2), was repealed by Pub. L. 115–271, title VIII, § 8203(b)(5), Oct. 24, 2018, 132 Stat. 4112. AMENDMENTS 2019—Par. (9). Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(2). See 2018 Amendment note below. 2018—Par. (9). Pub. L. 115–271, § 8203(b)(2), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), added par. (9) and struck out former par. (9) which defined ‘‘substance abuse’’. Statutory Notes and Related Subsidiaries EFFECTIVE DATE OF 2019 AMENDMENT Amendment by Pub. L. 116–74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115–271, see section 2(c)(2) of Pub. L. 116–74, set out as a note under section 1522 of this title. § 1524. Authorization of appropriations (a) In general There is authorized to be appropriated to the Office of National Drug Control Policy to carry out this subchapter $99,000,000 for each of fiscal years 2018 through 2023. (b) Administrative costs Not more than 8 percent of the funds appro- priated to carry out this subchapter may be used by the Office of National Drug Control Policy to pay administrative costs associated with the re- sponsibilities of the Office under this sub- chapter. (Pub. L. 100–690, title I, § 1024, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 226; amended Pub. L. 107–82, § 1(b), (c), Dec. 14, 2001, 115 Stat. 817; Pub. L. 109–469, title VIII, § 801, Dec. 29, 2006, 120 Stat. 3535; Pub. L. 115–271, title VIII, § 8203(a)(3)(A), (b)(3), formerly § 8203(a)(4)(A), (b)(3), Oct. 24, 2018, 132 Stat. 4111, renumbered Pub. L. 116–74, § 2(c)(1)(A)(i)(IV), Nov. 27, 2019, 133 Stat. 1157; Pub. L. 116–74, § 2(c)(1)(A)(i)(V), (ii)(II), Nov. 27, 2019, 133 Stat. 1157.) Editorial Notes AMENDMENTS 2019—Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(3). See 2018 Amendment note below. Pub. L. 116–74, § 2(c)(1)(A)(i)(V), made technical amendment to directory language of Pub. L. 115–271, § 8203(a)(3)(A). See 2018 Amendment note below. 2018—Pub. L. 115–271, § 8203(b)(3), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), added subsecs. (a) and (b) and struck out former subsecs. (a) and (b), which re- lated to authorization of appropriations and adminis- trative costs, respectively. Pub. L. 115–271, § 8203(a)(3)(A), formerly § 8203(a)(4)(A), as renumbered and amended by Pub. L. 116–74, § 2(c)(1)(A)(i)(IV), (V), amended directory language of Pub. L. 109–469, § 801. See 2006 Amendment notes below. 2006—Subsec. (a)(11) to (15). Pub. L. 109–469, § 801(a), as amended by Pub. L. 115–271, § 8203(a)(3)(A), added pars. (11) to (15). Subsec. (b). Pub. L. 109–469, § 801(b), as amended by Pub. L. 115–271, § 8203(a)(3)(A), amended subsec. (b) gen- erally. Prior to amendment, text read as follows: ‘‘Not more than the following percentages of the amounts authorized under subsection (a) of this section may be used to pay administrative costs: ‘‘(1) 10 percent for fiscal year 1998. ‘‘(2) 6 percent for fiscal year 1999. ‘‘(3) 4 percent for fiscal year 2000. ‘‘(4) 3 percent for fiscal year 2001. ‘‘(5) 6 percent for each of fiscal years 2002 through 2007.’’ 2001—Subsec. (a)(5) to (10). Pub. L. 107–82, § 1(b), added pars. (5) to (10) and struck out former par. (5) which read as follows: ‘‘$43,500,000 for fiscal year 2002.’’ Subsec. (b)(5). Pub. L. 107–82, § 1(c), added par. (5) and struck out former par. (5) which read as follows: ‘‘3 per- cent for fiscal year 2002.’’